Synogen

Synogen operates as a venture firm, specializing in the co-founding and strategic development of emerging companies, primarily across the biotechnology, medical technology, healthcare IT, and broader technology sectors. It provides capital and active partnership from inception through full commercial launch, leveraging deep industry expertise to nurture these ventures. The firm's approach focuses on building robust companies that address critical market needs with innovative solutions.

The firm was established in 2003 by Richard Allen, Richard Melker, and Donn Dennis. These founders brought significant entrepreneurial and operational experience, having previously been key principals at Regeneration Technologies, a successful University of Florida spinoff in the biomedical field. Their insight stemmed from a desire to apply their proven company-building methodology to a broader range of early-stage enterprises, fostering innovation and sustainable growth within high-potential markets.

Synogen's clientele consists of promising startup and seed-stage companies poised for expansion within its target industries. The firm's overarching vision centers on a philosophy of "doing good while doing well," aiming to make a positive societal impact through successful investments. It seeks to support entrepreneurs in translating groundbreaking ideas into viable businesses, thereby contributing to advancements in technology and healthcare.